Skip to content

Clinical trials

Alzheimer Disease trials in the United Kingdom with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Not applicable Country / region: United Kingdom Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20171
20181
20196
20211
20221
20234
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status4
Recruiting3
Not yet recruiting2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University College, London4
University of Nottingham2
Anglia Ruskin University1
Ascentys Ltd1
Bournemouth University1
Debiopharm International SA1
Imperial College London1
Limbic Limited1
Medical Research Council Cognition and Brain Sciences Unit1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease22
Dementia11
Cognitive Dysfunction4
Anxiety Disorders2
Dementia, Vascular2
Lewy Body Disease2
Mixed Dementias2
Anomia1
Aphasia, Primary Progressive1
Color Vision Defects1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.